Zhang Jing, Chen Fangman, Wang Yongli, Chen Yahong
Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing 100191, China.
Research Center for Chronic Airway Disease, Peking University Health Science Center, Beijing 100191, China.
Chin Med J Pulm Crit Care Med. 2023 Jun 2;1(2):102-107. doi: 10.1016/j.pccm.2023.04.004. eCollection 2023 Jun.
Chronic Obstructive Pulmonary Disease (COPD) is characterized by persistent respiratory symptoms and airflow limitation. Acute exacerbation of COPD (AECOPD) is an acute worsening of respiratory symptoms, which needs additional treatment and can result in worsening health status, increasing risks of hospitalization and mortality. Therefore, it is necessary to early recognize and diagnose exacerbations of COPD. This review introduces the updated definition of COPD exacerbations, the current clinical assessment tools, and the current potential biomarkers. The application of mobile health care in COPD management for early identification and diagnosis is also included in this review.
慢性阻塞性肺疾病（COPD）的特征是持续的呼吸道症状和气流受限。慢性阻塞性肺疾病急性加重（AECOPD）是呼吸道症状的急性恶化，需要额外治疗，可导致健康状况恶化、住院风险和死亡率增加。因此，早期识别和诊断慢性阻塞性肺疾病急性加重非常必要。本综述介绍了慢性阻塞性肺疾病急性加重的最新定义、当前的临床评估工具以及当前潜在的生物标志物。本综述还包括移动医疗在慢性阻塞性肺疾病管理中用于早期识别和诊断的应用。
